Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Trevi Therapeutics, Inc. (TRVI)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Net income  -7.1-6.4-5.5-8.3-8.1-7.3-8.5-7.3
Depreciation and amortization   [+]0.00.00.00.00.00.00.00.0
Stock-based compensation    -1.80.6  -2.00.5
Change in working capital   [+]  0.3-0.8  0.1-0.7
Other operating activities  -2.8-1.80.7-0.11.90.24.20.2
Cash from operations  -9.9-8.2-6.3-8.6-6.2-7.1-6.2-7.2
   
Capital expenditures  0.00.10.20.00.00.00.00.0
Purchases of short-term investments, net  19.727.0187.2-4.854.2   
Other cash from investing  -0.1-18.1-235.7 -108.4   
Cash from investing  19.69.0-48.3-4.9-54.20.00.00.0
   
Repurchase of common stock, net    -103.051.2    
Option exercises  0.00.1 0.10.0 0.0 
Financing costs    0.0   0.1-0.1
Other cash from financing  -7.7-1.6103.74.256.0-0.613.80.1
Cash from financing  -7.7-1.70.755.356.0-0.613.70.1
   
Free cash flow  -9.8-8.1-6.1-8.6-6.2-7.1-6.2-7.2
        Per share (diluted)  ($0.10)($0.08)($0.09)($0.13)($0.10)($0.23)($0.27)($0.34)
   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy